| Disease | b-cell lymphomas | 
| Comorbidity | C0019158|hepatitis | 
| Sentences | 9 | 
| PubMedID- 24270404 | Outcome prediction of diffuse large b-cell lymphomas associated with hepatitis c virus infection: a study on behalf of the fondazione italiana linfomi. | 
| PubMedID- 22736295 | Clinical outcome in diffuse large b-cell lymphoma with hepatitis c virus infection in the rituximab era: a single center experience. | 
| PubMedID- 20554488 | Hcv-positive status and hepatitis flares in patients with b-cell non-hodgkin's lymphoma treated with rituximab-containing regimens. | 
| PubMedID- 25381127 | The notch pathway is recurrently mutated in diffuse large b-cell lymphoma associated with hepatitis c virus infection. | 
| PubMedID- 22395482 | b-cell lymphoma in hepatitis c virus (hcv)-seropositive patients frequently presents with extranodal disease in the bone marrow, major salivary glands, or spleen [1, 2]. | 
| PubMedID- 24060287 | Bendamustine and rituximab for indolent b-cell non-hodgkin lymphoma in patients with compensated hepatitis c cirrhosis: a case series. | 
| PubMedID- 25339404 | Fatal outcome of autochthonous hepatitis e in a patient with b cell lymphoma in southeastern france. | 
| PubMedID- 25848698 | We performed a retrospective study to analyse the characteristics and clinical outcomes of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis b virus (hbv) infection and compare with those without hbv infection. | 
| PubMedID- 23465418 | Early-stage splenic diffuse large b-cell lymphoma is highly associated with hepatitis c virus infection. | 
Page: 1 


